HICKSVILLE, NY (PRWEB) May 20, 2018
Retina Group of New York (RGONY) is proud to be a corporate Gold Sponsor of the Juvenile Diabetes Research Foundation (JDRF) Gala: One Night in Vegas on Friday, June 1, 2018 at the Crest Hollow Country Club in Woodbury, New York.
James M. Maisel, MD, a retinal specialist, and CEO and founder of the Retina Group of New York was honored as the Humanitarian of the Year at the 2017 JDRF Gala. According to Dr. Maisel “Over 10% of the American population is currently afflicted with diabetes and many more are undiagnosed or prediabetic. It is a chronic disease with many complications and accounts for a substantial portion of our healthcare costs. Funding is needed to do further research to prevent, delay, cure and mitigate diabetes and its complications. The Juvenile Diabetes Research Foundation is dedicated to finding a cure and we hope other physicians will help to support their efforts.”
Dr. Maisel frequently lectures about diabetes and its effect on the eye. "http://rgony.com/diabetic-r etinopathy/ [Diabetes can affect the eye __title__ Diabetic eye disease] in many ways and although extremely treatable, it remains one of the leading causes of blindness and blurred vision in adults. Diabetic eye disease often has no early warning symptoms or pain. When advanced, it can cause blurred vision, floaters or total visual loss, but don’t wait until you notice problems with your vision. A dilated retina examination can detect diabetic retinopathy before vision loss begins. Healthy people need eye exams every three years and yearly after age 65. Diabetics should be evaluated yearly even without symptoms. While laser treatments at the proper time can prevent blindness for over 90% of patients, vitreous surgery can restore vision in others even with advanced complications such as vitreous hemorrhage or tractional retinal detachments. Blurred vision, that formerly was only slowed with focal laser treatment, can now be stabilized or improved in most patients with pharmacologic treatments administered in the office on a routine basis.”
Be part of the JDRF Gala: One Night in Vegas on Friday, June 1, 2018 at the Crest Hollow Country Club in Woodbury, New York. One Night in Vegas brings people together to celebrate the tenacity and courage displayed by the type one diabetes (T1D) community, while raising money to fund T1D research. At this festive evening you can expect gambling for prizes, drinks, food, music and fun. Bring your friends, family and co-workers to this event and help us change the future of diabetes. The money you raise WILL make a difference. Together we can stop diabetes and have fun. Register today at 212-478-4324 or contact TLee@jdrf.org.
About the Juvenile Diabetes Research Foundation
The Juvenile Diabetes Research Foundation (http://www.JDRF.org) is the leading global organization funding type 1 diabetes (T1D) research. Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. The JDRF vision is a world without type 1 diabetes. Its mission is accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications. As the largest non-governmental funder of T1D research, JDRF has a proven track record of success. Since its founding, JDRF has aggressively raised awareness, raise or directed nearly $5 billion to researching a cure and supported the T1D community. JDRF drives innovation, demands action and stands with everyone facing life with type 1 diabetes.
About the Retina Group of New York
The Retina Group of New York has provided tertiary retinal care to patients in Nassau and Suffolk Counties since 1986 at its offices in Hicksville and Hauppauge. Both locations are fully equipped with in-office laser capabilities, cutting edge diagnostic imaging, and integrated electronic records. The group holds staff privileges at seven area hospitals and teaching appointments at the Hofstra North Shore-LIJ School of Medicine, North Shore University Hospital, and Nassau University Medical Center. The practice is limited to medical and surgical retinal problems. These commonly include diabetic retinopathy, macular degeneration, retinal vein occlusion, retinal detachment, macula pucker, macula hole, cataract surgery complications, uveitis, Plaquenil toxicity and second opinions.
The group, led by CEO and founder James Maisel, MD, consists of Board Certified Ophthalmologists who have additional Fellowship Training from top institutions including New York Presbyterian-Cornell Medical Center. They are complemented by specialized ophthalmic certified RNs, Health Information Management Specialists and Ophthalmic Technicians. The Retina Group of New York utilizes state-of-the-art diagnostic equipment and offers in office laser treatment for diabetic retinopathy and treatment for diabetic macular edema with intravitreal medications including Eylea®, Lucentis®, Ozurdex® and Iluvien®. Members of the group serve on the medical advisory boards of Regeneron, Allergan, Genentech and Alimera keeping abreast of the latest treatments and lecture around the country to other retina specialists about diabetic retinopathy. Dr. Maisel’s software company, ZyDoc Medical Transcription was a a finalist in the Sanofi 2013 Data Design Diabetes Innovation Challenge – Prove It! He was honored as Humanitarian of the Year at the 2017 JDRF Gala. He is an editor for the Journal of Diabetes Science and Technology, Section on Big Data and Diabetes. He Co-Chaired the 5th World Diabetes Congress in Prague in 2017 and presented on “Using NLP to Identify and Manage Patient Populations at Risk for Diabetes and Complications” and “Ocular Complications of Diabetes Mellitus and Laser, Surgery and Pharmacologic Treatment for Diabetic Retinopathy.”
For more information about diabetic retinopathy, contact the Retina Group of New York at http://www.rgony.com or visit them at:
Retina Group of New York Long Island Offices
400 S. Oyster Bay Road
Hicksville, NY 11801
1455 Veterans Memorial Highway
Hauppauge, NY 11788
Read the full story at http://www.prweb.com/releases/2018/05/prweb15501431.htm